Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

The role of innate immunity in promoting microbiota-dependent mucus production in the proximal colon

EF 2022-23

Résumé
Inflammatory Bowel Disease (IBD) is a chronic disorder of the gut in which the intestinal walls are bombarded by the immune system, leading to ulceration and diarrhea. The cause is unknown, but has been associated with the gut microbiota (all the microorganisms found in the gut). These microbes are separated from the host by a thick gel-like mucus layer composed of sugar-rich proteins known as mucins. These mucins function to keep the microorganisms ‘at bay’, but also provide a ‘niche’ where good microbes can live. A disrupted mucus layer is commonly associated with IBD. We know that microbes stimulate mucus production, but how exactly is unknown. By understanding how this occurs, we may be able to boost mucus production to improve the host-microbiome interaction in IBD. This project will seek to determine how microbes are stimulating mucus production, specifically through interactions with Toll-like Receptors (TLRs), receptors present on host cells in the gut that represent the ‘front interface’ of the immune system. To accomplish this, I will utilize a complex “ex-plant” system, in which I will measure the production of mucus in live portions of mouse colon in response to a variety of microbe related-molecules. I will also utilize several specialized groups of mice: mice lacking a microbiota, mice with a human microbiota, and a genetically altered group that lacks TLR function; with and without a human microbiota. Using these models, I will track the development of the mucus barrier over time to determine the roll of the microbiome and TLRs in mucus formation. This research will provide valuable insight into the microbiota’s role in the essential production of mucus, and will point to new strategies and targets in understanding and combatting IBD.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
486486
Name
Fancy Noah M
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The role of innate immunity in promoting microbiota-dependent mucus production in the proximal colon
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Colitis/Inflammatory Bowel Disease; Colon; Ex Vivo; Germ Free/Gnotobiotic; Goblet Cell; Humanized Microbiota; In Vivo; Microbiota; Mucus; Pattern Recognition Receptors
Abstract
Inflammatory Bowel Disease (IBD) is a chronic disorder of the gut in which the intestinal walls are bombarded by the immune system, leading to ulceration and diarrhea. The cause is unknown, but has been associated with the gut microbiota (all the microorganisms found in the gut). These microbes are separated from the host by a thick gel-like mucus layer composed of sugar-rich proteins known as mucins. These mucins function to keep the microorganisms ‘at bay’, but also provide a ‘niche’ where good microbes can live. A disrupted mucus layer is commonly associated with IBD. We know that microbes stimulate mucus production, but how exactly is unknown. By understanding how this occurs, we may be able to boost mucus production to improve the host-microbiome interaction in IBD. This project will seek to determine how microbes are stimulating mucus production, specifically through interactions with Toll-like Receptors (TLRs), receptors present on host cells in the gut that represent the ‘front interface’ of the immune system. To accomplish this, I will utilize a complex “ex-plant” system, in which I will measure the production of mucus in live portions of mouse colon in response to a variety of microbe related-molecules. I will also utilize several specialized groups of mice: mice lacking a microbiota, mice with a human microbiota, and a genetically altered group that lacks TLR function; with and without a human microbiota. Using these models, I will track the development of the mucus barrier over time to determine the roll of the microbiome and TLRs in mucus formation. This research will provide valuable insight into the microbiota’s role in the essential production of mucus, and will point to new strategies and targets in understanding and combatting IBD.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Fancy, Noah M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~